LIPID MEDIATOR PRODUCTION IN ACUTE AND CHRONIC-PANCREATITIS IN THE RAT

被引:22
作者
ZHOU, WG [1 ]
LEVINE, BA [1 ]
OLSON, MS [1 ]
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT SURG,SAN ANTONIO,TX 78284
关键词
D O I
10.1006/jsre.1994.1007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Pancreatic production of lipid mediators of inflammation, including eicosanoids and platelet-activating factor (PAF), was examined in two models of pancreatitis in the rat. Chronic pancreatitis was induced by ligation of the pancreatic duct and acute pancreatitis by infusion of sodium taurocholate into the pancreatic duct. In the model of chronic pancreatitis, prostaglandin E2 (PGE2), PGD2, 6-keto PGF(1α), thromboxane B2 (TXB2), and PAF increased significantly in the pancreas in a similar fashion, whereas leukotriene B4 (LTB4) remained unchanged. BN52021, a PAF antagonist, reduced the accumulation of pancreatic TXB2, 6-keto PGF(1α), and PGD2, and did not affect PGE2. In the model of acute pancreatitis, LTB4 increased, whereas PGE2, TXB2, and 6-keto PGF(1α) decreased significantly; PGD2 changed slightly; and PAF was undetectable. The present results indicate that mild chronic pancreatitis is accompanied by the production and accumulation of a wide spectrum of lipid mediators while LTB4 was the only lipid mediator detected at biologically active concentrations in the model of severe acute pancreatitis. It is suggested that various mediators are involved in establishing a balance between inflammation and the repair of the inflamed pancreatic tissue observed in mild chronic pancreatitis. While both eicosanoids and PAF are involved in such self-limiting responses to inflammatory challenge, PAF seems to play a central role in instigating the production of the various other mediators detected in the model of chronic pancreatitis. In the model of acute pancreatitis while the deficiency of various lipid mediators may render the pancreatic tissue more susceptible to acute damage, enhanced LTB4 appears to contribute to the destructive pathology observed. In conclusion, the diversity of the pancreatic inflammatory responses associated with changes in the production of lipid mediators (hypersecretion or hyposecretion) suggests not only the pathophysiological importance of the individual mediators but also rational strategies for therapeutic intervention. © 1994 Academic Press, Inc.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 42 条
[1]   INTERACTION BETWEEN PAF-ACETHER AND DRUGS THAT STIMULATE CYCLIC-AMP IN GUINEA-PIG ALVEOLAR MACROPHAGES [J].
BACHELET, M ;
ADOLFS, MJP ;
MASLIAH, J ;
BEREZIAT, G ;
VARGAFTIG, BB ;
BONTA, IL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (1-2) :73-78
[2]  
BENCOSME SA, 1956, ARCH PATHOL, V62, P285
[3]   STRUCTURAL-ANALYSIS OF PURIFIED PLATELET-ACTIVATING FACTOR BY LIPASES [J].
BENVENISTE, J ;
LECOUEDIC, JP ;
POLONSKY, J ;
TENCE, M .
NATURE, 1977, 269 (5624) :170-171
[4]  
BENVENISTE J, 1986, ADV INFLAMMAT RES, V10, P7
[5]   PROSTAGLANDIN-F2-ALPHA AND PROSTACYCLIN TISSUE-LEVELS IN EARLY PHASES OF TRYPSIN-INDUCED ACUTE-PANCREATITIS IN RATS [J].
BERGER, Z ;
BALINT, GA ;
PAP, A ;
KARACSONY, G ;
VARRO, V .
PANCREAS, 1989, 4 (03) :295-299
[6]   IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR ISOLATION OF PLATELET-ACTIVATING FACTOR FROM OTHER PHOSPHOLIPIDS [J].
BLANK, ML ;
SNYDER, F .
JOURNAL OF CHROMATOGRAPHY, 1983, 273 (02) :415-420
[7]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[8]   PROTECTIVE EFFECT OF MISOPROSTOL, A SYNTHETIC PROSTAGLANDIN-E1 ANALOG, ON EXPERIMENTAL PANCREATITIS INDUCED BY PANCREATIC DUCT LIGATION IN RAT [J].
BUSCAIL, L ;
SENEGASBALAS, F ;
BALAS, D ;
BOUISSON, M ;
BERTRAND, C ;
RIBET, A .
PANCREAS, 1989, 4 (06) :715-723
[9]   INHIBITORY EFFECT OF PROSTACYCLIN (PGI2) ON NEUTROPENIA INDUCED BY INTRAVENOUS-INJECTION OF PLATELET-ACTIVATING-FACTOR (PAF) IN THE RABBIT [J].
CAMUSSI, G ;
TETTA, C ;
BUSSOLINO, F .
PROSTAGLANDINS, 1983, 25 (03) :343-351
[10]  
CAMUSSI G, 1983, AGENTS ACTIONS, V11, P550